BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 8 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,508,000 | -34.1% | 40,000 | -42.9% | 0.02% | -75.9% |
| Q3 2020 | $5,326,000 | +49.9% | 70,000 | +75.0% | 0.08% | +71.7% |
| Q1 2019 | $3,553,000 | +4.3% | 40,000 | 0.0% | 0.05% | 0.0% |
| Q4 2018 | $3,406,000 | +9.1% | 40,000 | +14.3% | 0.05% | -31.3% |
| Q4 2017 | $3,121,000 | -16.2% | 35,000 | -12.5% | 0.07% | -28.0% |
| Q3 2017 | $3,723,000 | -71.9% | 40,000 | -72.6% | 0.09% | -65.2% |
| Q2 2017 | $13,251,000 | +13.0% | 145,900 | +9.2% | 0.27% | +69.0% |
| Q1 2017 | $11,727,000 | -71.0% | 133,600 | -72.7% | 0.16% | -62.6% |
| Q4 2016 | $40,476,000 | +201.7% | 488,600 | +237.0% | 0.42% | +30.6% |
| Q3 2016 | $13,415,000 | -6.8% | 145,000 | -21.6% | 0.32% | -27.4% |
| Q2 2016 | $14,393,000 | +20.3% | 185,000 | +27.6% | 0.45% | -20.8% |
| Q1 2016 | $11,960,000 | +2.9% | 145,000 | +70.6% | 0.56% | +62.2% |
| Q2 2015 | $11,626,000 | -22.3% | 85,000 | -29.2% | 0.35% | -12.6% |
| Q1 2015 | $14,954,000 | – | 120,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 2,027 | $17,774,000 | 0.02% |
| Hudson Bay Capital Management LP | 40,000 | $3,508,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 103,800 | $9,102,000 | 0.02% |
| IMC-Chicago, LLC | 64,200 | $5,630,000 | 0.01% |
| JPMORGAN CHASE & CO | 353,400 | $30,990,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |